{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:18:55Z","timestamp":1777058335819,"version":"3.51.4"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T00:00:00Z","timestamp":1435536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0131670","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T18:32:51Z","timestamp":1435602771000},"page":"e0131670","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy"],"prefix":"10.1371","volume":"10","author":[{"given":"Stephanie","family":"Str\u00f6bele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Schneele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus D.","family":"Siegelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Nonnenmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Karpel-Massle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike-Andrew","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Eric","family":"Halatsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus-Michael","family":"Debatin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11060-011-0749-4","article-title":"Glioblastoma survival in the United States before and during the temozolomide era","volume":"107","author":"DR Johnson","year":"2011","journal-title":"J Neurooncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"R Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrc2818","article-title":"Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma","volume":"10","author":"JT Huse","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"ref4","first-page":"153","article-title":"Glioma invasion\u2014pattern of dissemination by mechanisms of invasion and surgical intervention, pattern of gene expression and its regulatory control by tumorsuppressor p53 and proto-oncogene ETS-1","volume":"88","author":"A Giese","year":"2003","journal-title":"Acta Neurochir Suppl"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ccr.2011.11.005","article-title":"Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma","volume":"20","author":"M Snuderl","year":"2011","journal-title":"Cancer Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ccr.2011.11.018","article-title":"Many tumors in one: a daunting therapeutic prospect","volume":"20","author":"CI Ene","year":"2011","journal-title":"Cancer Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.3390\/ijms15033746","article-title":"Killing me softly-future challenges in apoptosis research","volume":"15","author":"MA Westhoff","year":"2014","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"key":"ref9","first-page":"279","article-title":"Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance","volume":"347","author":"QW Fan","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00280-012-2043-3","article-title":"Overcoming acquired resistance to anticancer therapy: focus on the PI3K\/AKT\/mTOR pathway","volume":"71","author":"HA Burris 3rd","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathol-011110-130324","article-title":"Glioblastoma: from molecular pathology to targeted treatment","volume":"9","author":"TF Cloughesy","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12094-013-1109-y","article-title":"Efficacy of rapamycin against glioblastoma cancer stem cells","volume":"16","author":"M Mendiburu-Elicabe","year":"2014","journal-title":"Clin Transl Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/neuonc\/noq052","article-title":"mTOR signaling in glioblastoma: lessons learned from bench to bedside","volume":"12","author":"D Akhavan","year":"2010","journal-title":"Neuro Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1158\/0008-5472.CAN-07-6769","article-title":"Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis","volume":"68","author":"D Opel","year":"2008","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1038\/onc.2009.215","article-title":"The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair","volume":"28","author":"MA Westhoff","year":"2009","journal-title":"Oncogene"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e83128","DOI":"10.1371\/journal.pone.0083128","article-title":"Sequential Dosing in Chemosensitization: Targeting the PI3K\/Akt\/mTOR Pathway in Neuroblastoma","volume":"8","author":"MA Westhoff","year":"2013","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Enzenmuller S, Gonzalez P, Karpel-Massler G, Debatin KM, Fulda S (2012) GDC-0941 enhances the lysosomal compartment via TFEB and primes glioblastoma cells to lysosomal membrane permeabilization and cell death. Cancer Lett.","DOI":"10.1016\/j.canlet.2012.09.007"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1593\/tlo.12364","article-title":"Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule","volume":"6","author":"S Kuger","year":"2013","journal-title":"Transl Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1158\/1078-0432.CCR-13-1607","article-title":"Inhibition of DNA double-strand break repair by the dual PI3K\/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma","volume":"20","author":"CR Gil del Alcazar","year":"2014","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-14-17","article-title":"Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases","volume":"14","author":"EJ Choi","year":"2014","journal-title":"BMC Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1002\/ijc.29138","article-title":"RIST: A potent new combination therapy for glioblastoma","volume":"136","author":"L Nonnenmacher","year":"2015","journal-title":"Int J Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/sj.onc.1210850","article-title":"The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids","volume":"27","author":"Hamer PC De Witt","year":"2008","journal-title":"Oncogene"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/18715206113136660340","article-title":"Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines","volume":"14","author":"G Karpel-Massler","year":"2014","journal-title":"Anticancer Agents Med Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1038\/onc.2008.148","article-title":"Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells","volume":"27","author":"MA Westhoff","year":"2008","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1128\/MCB.24.18.8113-8133.2004","article-title":"SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling","volume":"24","author":"MA Westhoff","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/leu.2008.144","article-title":"PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML","volume":"22","author":"S Park","year":"2008","journal-title":"Leukemia"},{"key":"ref27","first-page":"97","article-title":"A novel dual PI3Kalpha\/mTOR inhibitor PI-103 with high antitumor activity in non-small cell lung cancer cells","volume":"24","author":"ZQ Zou","year":"2009","journal-title":"Int J Mol Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/0008-5472.CAN-10-1601","article-title":"A dual PI3K\/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models","volume":"71","author":"T Bagci-Onder","year":"2011","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/bjc.1985.259","article-title":"Antitumour imidazotetrazines\u2014XI: Effect of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one [CCRG 81045; M and B 39831 NSC 362856] on poly(ADP-ribose) metabolism","volume":"52","author":"MJ Tisdale","year":"1985","journal-title":"Br J Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00003088-199733040-00001","article-title":"Clinical pharmacokinetics of irinotecan","volume":"33","author":"GG Chabot","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ctrv.2008.03.125","article-title":"DNA repair and cancer stem-like cells\u2014potential partners in glioma drug resistance?","volume":"34","author":"TC Johannessen","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-211-78741-0_1","article-title":"Present and potential future adjuvant issues in high-grade astrocytic glioma treatment","volume":"34","author":"F Lefranc","year":"2009","journal-title":"Adv Tech Stand Neurosurg"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1158\/0008-5472.CAN-12-0334","article-title":"Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency","volume":"72","author":"WL See","year":"2012","journal-title":"Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3892\/or.2013.2485","article-title":"ERK and PI3K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells","volume":"30","author":"ZX Cong","year":"2013","journal-title":"Oncol Rep"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3892\/ijo.2014.2322","article-title":"miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K\/ATK and Raf\/MEK\/ERK pathways","volume":"44","author":"Z Liu","year":"2014","journal-title":"Int J Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e95060","DOI":"10.1371\/journal.pone.0095060","article-title":"MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K\/AKT signaling pathways","volume":"9","author":"Y Yao","year":"2014","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1158\/1535-7163.MCT-05-0099","article-title":"Combined inhibition of the phosphatidylinositol 3-kinase\/Akt and Ras\/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells","volume":"5","author":"LA Edwards","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e76505","DOI":"10.1371\/journal.pone.0076505","article-title":"MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signaling","volume":"8","author":"C Evans","year":"2013","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e87281","DOI":"10.1371\/journal.pone.0087281","article-title":"Glioma cell proliferation controlled by ERK activity-dependent surface expression of PDGFRA","volume":"9","author":"D Chen","year":"2014","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0960-9822(03)00544-X","article-title":"A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src","volume":"13","author":"NO Carragher","year":"2003","journal-title":"Curr Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/stem.696","article-title":"FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity","volume":"29","author":"J Sunayama","year":"2011","journal-title":"Stem Cells"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.18632\/oncotarget.1164","article-title":"PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1","volume":"4","author":"A Gont","year":"2013","journal-title":"Oncotarget"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","article-title":"Cancer stem cells: impact, heterogeneity, and uncertainty","volume":"21","author":"JA Magee","year":"2012","journal-title":"Cancer Cell"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10571-014-0031-3","article-title":"Cells isolated from human glioblastoma multiforme express progesterone-induced blocking factor (PIBF)","volume":"34","author":"D Kyurkchiev","year":"2014","journal-title":"Cell Mol Neurobiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/jcb.22350","article-title":"Cancer stem cells: cell culture, markers, and targets for new therapies","volume":"108","author":"CA Gilbert","year":"2009","journal-title":"J Cell Biochem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nbt0207-193","article-title":"Targeting brain-tumor stem cells","volume":"25","author":"R Stupp","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1091\/mbc.E10-04-0335","article-title":"The proliferation rate paradox in antimitotic chemotherapy","volume":"23","author":"TJ Mitchison","year":"2012","journal-title":"Mol Biol Cell"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.2005.05881.x","article-title":"Inhibition of the phosphatidylinositol-3 kinase\/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma","volume":"132","author":"GV Georgakis","year":"2006","journal-title":"Br J Haematol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1158\/1541-7786.MCR-07-0280","article-title":"Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas","volume":"6","author":"A Li","year":"2008","journal-title":"Mol Cancer Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1158\/1078-0432.CCR-04-2115","article-title":"Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme","volume":"11","author":"TW Vogel","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1158\/1078-0432.CCR-07-2141","article-title":"Is cell death a critical end point for anticancer therapies or is cytostasis sufficient?","volume":"13","author":"O Rixe","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1158\/0008-5472.CAN-05-2769","article-title":"Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma","volume":"66","author":"L Chesler","year":"2006","journal-title":"Cancer Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4161\/cbt.28585","article-title":"Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K\/mTOR dual inhibitor PF-05212384","volume":"15","author":"Y Zhu","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1750-3639.1999.tb00536.x","article-title":"Frequent co-alterations of TP53, p16\/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines","volume":"9","author":"N Ishii","year":"1999","journal-title":"Brain Pathol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0163-7258(01)00132-2","article-title":"Differentiation therapy of human cancer: basic science and clinical applications","volume":"90","author":"M Leszczyniecka","year":"2001","journal-title":"Pharmacol Ther"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3892\/mmr.2013.1434","article-title":"Role of PTEN in cholera toxin-induced SWO38 glioma cell differentiation","volume":"7","author":"MH Wang","year":"2013","journal-title":"Mol Med Rep"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/aps.2010.10","article-title":"Glycogen synthase kinase-3beta regulates astrocytic differentiation of U87-MG human glioblastoma cells","volume":"31","author":"Y Li","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/neuonc\/noq103","article-title":"Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells","volume":"12","author":"J Sunayama","year":"2010","journal-title":"Neuro Oncol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2052-8426-2-32","article-title":"A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy","volume":"2","author":"M-A Westhoff","year":"2014","journal-title":"Molecular and Cellular Therapies"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1748-717X-7-25","article-title":"Post-radiation increase in VEGF enhances glioma cell motility in vitro","volume":"7","author":"WJ Kil","year":"2012","journal-title":"Radiat Oncol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0134770","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0131670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T19:11:56Z","timestamp":1717960316000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0131670"}},"subtitle":[],"editor":[{"given":"Javier S","family":"Castresana","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,29]]},"references-count":60,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0131670","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,29]]}}}